News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

India Dismisses Bayer AG (BAY.F) Petition to Block Cipla Ltd. Generic Cancer Drug


12/3/2010 7:57:11 AM

Economic Times -- NEW DELHI: The country’s top judicial authority has dismissed German pharmaceutical firm Bayer AG’s attempt to block Indian drug regulator from allowing Mumbai-based Cipla Ltd to launch a low-cost version of its patented cancer medicine. Had Bayer won the case, it would have supported ‘patent linkage’ , a provision that links marketing approval for introduction of a low-cost drug to the patent status of its original product.

Read at Times of India
Read at EconomicTimes
Read at Live Mint

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES